AMH Test and IVF Success: Complete Prediction Guide

The AMH test is the single most useful predictor of how your ovaries will respond during IVF stimulation. Unlike FSH or antral follicle count alone, AMH provides a stable, cycle-independent measurement that directly correlates with the number of eggs retrievable during an IVF cycle. This guide explains exactly how fertility clinics use your AMH result to design your IVF protocol, predict your response category, estimate egg yield, and counsel you on realistic expectations for live birth. AMH does not determine whether IVF will work for you — it determines how your IVF should be managed.

This guide was developed by the WellAlly Fertility Team, comprising board-certified reproductive endocrinologists and IVF specialists who collectively manage over 2,000 IVF cycles annually at SART-member clinics. The clinical data presented here is sourced from the American Society for Reproductive Medicine (ASRM) committee opinions, peer-reviewed meta-analyses published in Fertility and Sterility and Human Reproduction Update, and the most recent SART National Summary Reports. All statistical claims reference published literature with sample sizes exceeding 10,000 patients where possible. Our medical reviewers practice at academic medical centers and follow evidence-based protocols consistent with ASRM and ESHRE guidelines.

One of the most common misconceptions about AMH is that it predicts whether IVF will succeed. It does not. AMH predicts ovarian response — the number of follicles your ovaries will develop and the number of eggs your doctor can retrieve during stimulation.

The distinction matters because live birth depends primarily on egg quality, which is driven by age, not AMH. A 32-year-old woman with an AMH of 0.5 ng/mL has a better per-cycle live birth rate than a 42-year-old woman with an AMH of 3.0 ng/mL, because younger eggs are chromosomally normal at higher rates regardless of how many are available.

What AMH Actually Measures

AMH is produced by the granulosa cells of pre-antral and small antral follicles in the ovary. The total AMH level in your blood reflects the size of your residual follicle pool — essentially how many eggs remain in the ovaries and are potentially available for recruitment during an IVF cycle.

Key characteristics of AMH as an IVF biomarker:

• Cycle-independent: Can be drawn on any day of the menstrual cycle
• Stable within a cycle: Minimal intra-cycle variation
• Declines with age: Predictable decrease beginning in the late 20s
• Reflects follicle pool: Directly proportional to the number of recruitable follicles

Fertility clinics classify patients into three response categories based on AMH. These categories drive protocol selection and dosing decisions.

Note: AMH units vary by laboratory. The conversion factor is approximately 1 ng/mL = 7.14 pmol/L.

Poor Responders (AMH ＜ 0.7 ng/mL)

Women classified as poor responders produce fewer than five eggs per retrieval. This does not mean IVF will fail. Clinical strategies include:

• Higher gonadotropin dosing (300-450 IU daily)
• Flare protocols or antagonist protocols with oral adjuncts (clomiphene or letrozole)
• Dual stimulation (duostim) protocols in the same cycle
• Accumulation of embryos across multiple retrievals before transfer

Normal Responders (AMH 0.7-3.5 ng/mL)

This is the optimal response range. Most IVF protocols are designed around this group. Standard antagonist protocols with 150-225 IU of gonadotropins typically yield 8-15 mature eggs, which provides sufficient embryos for fresh transfer and cryopreservation.

High Responders (AMH > 3.5 ng/mL)

High AMH levels often indicate polycystic ovary syndrome (PCOS) or polycystic ovarian morphology (PCOM). While these patients produce many eggs, they are at significantly increased risk for ovarian hyperstimulation syndrome (OHSS). Protocols emphasize:

• Lower starting doses (75-150 IU)
• GnRH antagonist protocols with GnRH agonist trigger (instead of hCG)
• Elective freeze-all strategies to prevent late-onset OHSS
• Close monitoring with frequent ultrasounds and estradiol levels

The following table shows expected egg yield across specific AMH values based on aggregated data from multiple SART-reporting clinics.

These numbers represent averages. Individual results vary based on age, body mass index, protocol adherence, and individual biological variation.

Your AMH level is one of the primary factors your reproductive endocrinologist uses to select your stimulation protocol.

AMH influences live birth rates primarily through its effect on the number of embryos available for transfer and genetic testing. The following table shows estimated live birth rates per IVF retrieval cycle stratified by both AMH level and maternal age.

Source: Adapted from SART National Summary Reports and published meta-analyses.

The key insight: within each age group, higher AMH confers an advantage because more eggs yield more embryos, increasing the chance of finding a chromosomally normal one. But the age effect dwarfs the AMH effect.

If your AMH is below 0.7 ng/mL, take these steps before starting an IVF cycle:

1. Confirm with a repeat test: AMH can fluctuate. Have the test repeated 4-6 weeks later to confirm the result, ideally at the same laboratory for consistency.

2. Optimize underlying health: Address thyroid dysfunction (TSH should be below 2.5 mIU/L), manage insulin resistance, achieve a BMI between 18.5-30, and begin prenatal vitamins with at least 800 mcg of folic acid.

3. Consider DHEA supplementation: Some studies suggest that 75 mg/day of DHEA for 6-12 weeks before IVF may improve outcomes in poor responders, though evidence is mixed. Discuss with your physician.

4. Review the clinic's experience with low AMH: Not all clinics are equally skilled at managing poor responders. Ask about their specific protocols, cancellation rates, and live birth rates for women with similar AMH levels.

5. Set realistic expectations: Understand that you may need multiple retrieval cycles to accumulate enough embryos, particularly if you plan to use preimplantation genetic testing (PGT-A).

Donor egg IVF becomes the recommended discussion point when the probability of achieving a live birth with your own eggs falls below an acceptable threshold based on your individual situation. Factors that influence this decision include:

• AMH consistently below 0.2 ng/mL with failed retrieval attempts
• Age over 43 regardless of AMH level
• Multiple IVF cycle failures with no chromosomally normal embryos
• Repeated poor embryo quality despite adequate egg numbers

Donor egg IVF has a live birth rate of approximately 50-60% per transfer regardless of the recipient's AMH, because the donor is typically under age 30.

Can I improve my AMH level before IVF?

No intervention has been conclusively shown to increase AMH levels. AMH reflects your ovarian reserve, which is a fixed biological parameter that declines with age. Supplements like DHEA or CoQ10 may improve egg quality and IVF outcomes, but they do not raise AMH. Focus on optimizing your overall health and choosing the right IVF protocol rather than trying to change your AMH number.

What AMH level is too low for IVF?

There is no AMH level that absolutely contraindicates IVF. Women with undetectable AMH have achieved live births through IVF, though the probability is low. The decision to proceed depends on your age, financial resources, emotional resilience, and willingness to attempt multiple cycles. Many clinics will attempt IVF with any detectable AMH level in women under 40.

Does high AMH guarantee more eggs than needed?

High AMH predicts a high egg yield, which is generally advantageous. However, excessively high AMH (above 8 ng/mL) may indicate PCOS and carries risks of OHSS and lower egg quality per egg retrieved. Your clinic will manage this with careful dosing and monitoring protocols.

How soon before IVF should I test AMH?

AMH should be tested at least 1-2 months before your planned IVF cycle to allow for protocol planning. Since AMH is cycle-independent, you can have it drawn at any time. If you have been on hormonal contraceptives, some clinics recommend waiting 1-2 months after discontinuation for the most accurate reading.

Is AMH more important than age for IVF success?

No. Age is the single most important factor in IVF success because it determines the percentage of eggs that are chromosomally normal. AMH determines how many eggs are available, but the quality of those eggs is governed primarily by age. A 38-year-old with high AMH still faces age-related chromosomal decline, while a 28-year-old with low AMH may achieve pregnancy with very few eggs.

1. AMH predicts egg quantity, not quality or live birth. It tells your doctor how many eggs to expect during retrieval, not whether those eggs will result in a baby.
2. Your AMH determines your IVF protocol. Low AMH means higher doses and modified protocols. High AMH means lower doses and OHSS prevention strategies.
3. Age trumps AMH for live birth prediction. A younger woman with low AMH generally has better outcomes than an older woman with high AMH.
4. Low AMH does not mean IVF will fail. It means you may need a modified approach, potentially multiple cycles, and realistic counseling about expectations.
5. AMH testing should occur before IVF planning. Knowing your AMH level early allows your clinic to select the optimal protocol before you invest time and money in treatment.
6. Donor eggs remain an option. If ovarian reserve is severely diminished, donor egg IVF offers live birth rates of 50-60% per transfer, making it one of the most effective treatments in reproductive medicine.